Alkermes Cash on Hand 2006-2019 | ALKS

Alkermes cash on hand from 2006 to 2019. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
Alkermes Annual Cash on Hand
(Millions of US $)
2018 $539
2017 $434
2016 $497
2015 $535
2014 $631
2013 $362
2013 $221
2012 $190
2011 $201
2010 $281
2009 $324
2008 $341
2007 $352
2006 $298
2005 $203
Alkermes Quarterly Cash on Hand
(Millions of US $)
Q3 2019 $587
Q2 2019 $570
Q1 2019 $582
Q4 2018 $539
Q3 2018 $467
Q2 2018 $434
Q1 2018 $405
Q4 2017 $434
Q3 2017 $450
Q2 2017 $475
Q1 2017 $476
Q4 2016 $497
Q3 2016 $549
Q2 2016 $656
Q1 2016 $625
Q4 2015 $535
Q3 2015 $772
Q2 2015 $777
Q1 2015 $747
Q4 2014 $631
Q3 2014 $573
Q2 2014 $638
Q1 2014 $552
Q4 2013 $362
Q3 2013 $339
Q2 2013 $229
Q1 2013 $221
Q4 2012 $209
Q3 2012 $199
Q2 2012 $164
Q1 2012 $246
Q4 2011 $213
Q3 2011 $216
Q2 2011 $248
Q1 2011 $201
Q4 2010 $177
Q3 2010 $230
Q2 2010 $292
Q1 2010 $281
Q4 2009 $239
Q3 2009 $295
Q2 2009 $317
Q1 2009 $324
Q4 2008 $345
Q3 2008 $332
Q2 2008 $371
Q1 2008 $341
Q4 2007 $511
Q3 2007 $358
Q2 2007 $326
Q1 2007 $352
Q4 2006 $351
Q3 2006 $320
Q2 2006 $369
Q1 2006 $298
Q4 2005 $314
Q3 2005 $336
Q2 2005 $339
Q1 2005 $203
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $3.287B $1.094B
Alkermes, Inc. is a biotechnology company that develops innovative medicines designed to yield better therapeutic outcomes and improve the lives of patients with serious disease. Alkermes currently has two commercial products: RISPERDAL CONSTA, the first and only long-acting atypical antipsychotic medication approved for use in schizophrenia, and marketed worldwide by Janssen-Cilag, a wholly owned division of Johnson & Johnson; and VIVITROL the first and only once-monthly injectable medication approved for the treatment of alcohol dependence and marketed in the U.S. primarily by Cephalon, Inc. Alkermes' pipeline includes extended-release injectable, pulmonary, and oral products for the treatment of prevalent, chronic diseases such as central nervous system disorders, addiction and diabetes.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $140.667B 16.20
CSL (CSLLY) Australia $87.267B 0.00
Gilead Sciences (GILD) United States $83.209B 10.31
Vertex Pharmaceuticals (VRTX) United States $56.311B 57.47
Biogen (BIIB) United States $53.561B 9.19
Illumina (ILMN) United States $47.734B 52.37
Regeneron Pharmaceuticals (REGN) United States $41.329B 18.10
Alexion Pharmaceuticals (ALXN) United States $24.435B 12.07
Incyte (INCY) United States $19.711B 45.76
Seattle Genetics (SGEN) United States $19.516B 0.00
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $16.617B 0.00
BioMarin Pharmaceutical (BMRN) United States $14.401B 0.00
Genmab (GNMSF) Denmark $13.473B 59.51
Alnylam Pharmaceuticals (ALNY) United States $13.127B 0.00
Galapagos (GLPG) Belgium $11.469B 29.55
Exact Sciences (EXAS) United States $11.321B 0.00
Bio-Rad Laboratories (BIO.B) United States $10.822B 51.94
Sarepta Therapeutics (SRPT) United States $9.843B 0.00
QIAGEN (QGEN) Netherlands $9.282B 30.26
Amarin (AMRN) Ireland $8.616B 0.00
BeiGene (BGNE) Cayman Islands $8.453B 0.00
Bio-Techne Corp (TECH) United States $8.119B 54.34
BioNTech SE (BNTX) Germany $7.342B 0.00
Guardant Health (GH) United States $7.127B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.829B 0.00
Medicines (MDCO) United States $6.714B 0.00
Reata Pharmaceuticals (RETA) United States $6.259B 0.00
Moderna (MRNA) United States $6.205B 0.00
Horizon Therapeutics Public (HZNP) Ireland $6.151B 15.64
ARGENX SE-ADR (ARGX) Netherlands $5.987B 0.00
Exelixis (EXEL) United States $5.415B 15.23
Bluebird Bio (BLUE) United States $4.966B 0.00
Ascendis Pharma (ASND) Denmark $4.854B 0.00
Repligen (RGEN) United States $4.612B 83.58
China Biologic Products (CBPO) China $4.605B 25.94
MorphoSys AG (MOR) Germany $4.485B 0.00
Mirati Therapeutics (MRTX) United States $4.427B 0.00
Spark Therapeutics (ONCE) United States $4.266B 0.00
Immunomedics (IMMU) United States $3.997B 0.00
Adaptive Biotechnologies (ADPT) United States $3.755B 0.00
Intercept Pharmaceuticals (ICPT) United States $3.737B 0.00
Blueprint Medicines (BPMC) United States $3.653B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.608B 0.00
UniQure (QURE) Netherlands $3.227B 0.00
MyoKardia (MYOK) United States $3.083B 0.00
Genmab (GMAB) Denmark $2.854B 5.88
Halozyme Therapeutics (HALO) United States $2.781B 0.00
NeoGenomics (NEO) United States $2.758B 146.78
Emergent Biosolutions (EBS) United States $2.683B 26.65
Acceleron Pharma (XLRN) United States $2.679B 0.00
Zai Lab (ZLAB) China $2.502B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.469B 0.00
Amicus Therapeutics (FOLD) United States $2.403B 0.00
Arena Pharmaceuticals (ARNA) United States $2.356B 5.48
RA PHARMCTL INC (RARX) United States $2.225B 0.00
Insmed (INSM) United States $2.074B 0.00
Myriad Genetics (MYGN) United States $1.903B 28.11
Ligand Pharmaceuticals (LGND) United States $1.862B 35.82
Dicerna Pharmaceuticals (DRNA) United States $1.833B 0.00
Denali Therapeutics (DNLI) United States $1.815B 0.00
Akcea Therapeutics (AKCA) United States $1.812B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.656B 0.00
Zymeworks (ZYME) Canada $1.654B 0.00
Principia Biopharma (PRNB) United States $1.630B 0.00
Epizyme (EPZM) United States $1.613B 0.00
REGENXBIO (RGNX) United States $1.606B 0.00
Editas Medicine (EDIT) United States $1.534B 0.00
Arvinas (ARVN) United States $1.435B 0.00
Fate Therapeutics (FATE) United States $1.420B 0.00
Innoviva (INVA) United States $1.394B 4.11
Alector (ALEC) United States $1.393B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.371B 0.00
Coherus BioSciences (CHRS) United States $1.299B 0.00
WAVE Life Sciences (WVE) Singapore $1.289B 0.00
Orchard Therapeutics (ORTX) United Kingdom $1.188B 0.00
Zealand Pharma (ZLDPF) Denmark $1.129B 0.00
Athenex (ATNX) United States $1.128B 0.00
Zealand Pharma (ZEAL) Denmark $1.015B 0.00
Pharming Group (PHGUF) Netherlands $1.013B 0.00
Sangamo Therapeutics (SGMO) United States $0.987B 0.00
Codexis (CDXS) United States $0.925B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.892B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.892B 7.50
Achillion Pharmaceuticals (ACHN) United States $0.877B 0.00
Twist Bioscience (TWST) United States $0.870B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $0.841B 0.00
Intellia Therapeutics (NTLA) United States $0.807B 0.00
Vericel (VCEL) United States $0.788B 294.00
MiMedx (MDXG) United States $0.782B 0.00
DBV Technologies S.A (DBVT) France $0.780B 0.00
Anika Therapeutics (ANIK) United States $0.758B 24.61
ANI Pharmaceuticals (ANIP) United States $0.739B 12.60
Heska (HSKA) United States $0.732B 186.92
Revance Therapeutics (RVNC) United States $0.721B 0.00
Intra-Cellular Therapies (ITCI) United States $0.709B 0.00
Clovis Oncology (CLVS) United States $0.705B 0.00
Adverum Biotechnologies (ADVM) United States $0.681B 0.00
Cellectis S.A (CLLS) France $0.677B 0.00
UROGEN PHARMA (URGN) United States $0.676B 0.00
Mesoblast (MESO) Australia $0.670B 0.00
Sorrento Therapeutics (SRNE) United States $0.670B 0.00
Cara Therapeutics (CARA) United States $0.663B 0.00
Cytokineticsorporated (CYTK) United States $0.629B 0.00
GENFIT S.A (GNFT) France $0.628B 0.00
Retrophin (RTRX) United States $0.616B 0.00
Kadmon Holdings (KDMN) United States $0.613B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.590B 0.00
PHARMA MAR SA (PHMMF) Spain $0.584B 0.00
Dynavax Technologies (DVAX) United States $0.580B 0.00
AC Immune SA (ACIU) Switzerland $0.577B 13.34
BioDelivery Sciences (BDSI) United States $0.573B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.540B 0.00
Agenus (AGEN) United States $0.527B 0.00
Precision BioSciences (DTIL) United States $0.523B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.516B 3.57
Prothena (PRTA) Ireland $0.513B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.508B 0.00
Stemline Therapeutics (STML) United States $0.504B 0.00
Sinovac Biotech (SVA) China $0.460B 0.00
AnaptysBio (ANAB) United States $0.427B 0.00
Avid Bioservices (CDMO) United States $0.410B 0.00
Arcus Biosciences (RCUS) United States $0.397B 0.00
Merus (MRUS) Netherlands $0.395B 0.00
Bellus Health (BLU) Canada $0.387B 0.00
PDL BioPharma (PDLI) United States $0.384B 9.60
AMAG Pharmaceuticals (AMAG) United States $0.378B 0.00
OSMOTICA PHARM (OSMT) United States $0.370B 0.00
Puma Biotechnology (PBYI) United States $0.365B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.344B 0.00
Gritstone Oncology (GRTS) United States $0.331B 0.00
Starpharma Holdings (SPHRY) Australia $0.327B 0.00
CytomX Therapeutics (CTMX) United States $0.325B 0.00
Cellular Biomedicine (CBMG) United States $0.321B 0.00
Kindred Biosciences (KIN) United States $0.319B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.314B 0.00
Cue Biopharma (CUE) United States $0.312B 0.00
Scholar Rock Holding (SRRK) United States $0.305B 0.00
Geron (GERN) United States $0.300B 0.00
Seres Therapeutics (MCRB) United States $0.294B 0.00
Kamada (KMDA) Israel $0.294B 8.58
Compugen (CGEN) Israel $0.290B 0.00
NantKwest (NK) United States $0.283B 0.00
MannKind (MNKD) United States $0.279B 0.00
ChromaDex (CDXC) United States $0.275B 0.00
Inovio Pharmaceuticals (INO) United States $0.272B 0.00
Exicure (XCUR) United States $0.261B 0.00
Sutro Biopharma (STRO) United States $0.257B 0.00
Albireo Pharma (ALBO) United States $0.257B 0.00
IVERIC Bio (ISEE) United States $0.246B 0.00
ADMA Biologics Inc (ADMA) United States $0.242B 0.00
Senesco Technologies (ELOX) United States $0.239B 0.00
Theratechnologies (THTX) Canada $0.234B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.231B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.227B 0.00
Biofrontera AG (BFRA) Germany $0.221B 0.00
Proteostasis Therapeutics (PTI) United States $0.217B 0.00
Spero Therapeutics (SPRO) United States $0.212B 0.00
XOMA (XOMA) United States $0.208B 0.00
POXEL SA FRANCE (PXXLF) France $0.203B 0.00
Protagonist Therapeutics (PTGX) United States $0.199B 0.00
Syros Pharmaceuticals (SYRS) United States $0.195B 0.00
Cerecor (CERC) United States $0.195B 0.00
Affimed (AFMD) Germany $0.194B 0.00
Athersys (ATHX) United States $0.194B 0.00
ARAVIVE, INC (ARAV) United States $0.190B 0.00
Abeona Therapeutics (ABEO) United States $0.187B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.181B 0.00
Mersana Therapeutics (MRSN) United States $0.178B 0.00
VBI Vaccines (VBIV) United States $0.174B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.162B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.158B 0.00
Five Prime Therapeutics (FPRX) United States $0.157B 0.00
Dyadic (DYAI) United States $0.153B 0.00
Windtree Therapeutics (WINT) United States $0.151B 0.00
Alcobra (ARCT) United States $0.150B 0.00
Aptinyx (APTX) United States $0.143B 0.00
Fortress Biotech (FBIO) United States $0.139B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.138B 0.00
Arsanis (XFOR) United States $0.135B 0.00
Newron Pharmaceuticals SpA (NWPHF) Italy $0.134B 0.00
Prometic Life Sciences (LMNL) Canada $0.134B 0.00
Northwest Biotherapeutics (NWBO) United States $0.133B 0.00
Arbutus Biopharma (ABUS) Canada $0.132B 0.00
TELA Bio (TELA) United States $0.128B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.128B 0.00
Nicox SA (NICXF) France $0.125B 0.00
Enzo Biochem (ENZ) United States $0.125B 0.00
SESEN BIO, INC (SESN) United States $0.115B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.109B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.108B 0.00
Novavax (NVAX) United States $0.107B 0.00
Menlo Therapeutics (MNLO) United States $0.105B 0.00
Celyad SA (CYAD) Belgium $0.102B 0.00
Emmaus Life Sciences (EMMA) United States $0.101B 0.00
Strongbridge Biopharma (SBBP) United States $0.100B 2.67
Verastem (VSTM) United States $0.100B 0.00
PHASEBIO PHARMA (PHAS) United States $0.097B 0.00
Aduro Biotech (ADRO) United States $0.090B 0.00
Antibe Therapeutics (ATBPF) Canada $0.089B 0.00
Adocia (ADOCY) France $0.086B 0.00
Acorda Therapeutics (ACOR) United States $0.085B 0.00
VTv Therapeutics (VTVT) United States $0.083B 0.00
OvaScience (MLND) United States $0.083B 0.00
Vaccinex (VCNX) United States $0.082B 0.00
Synlogic (SYBX) United States $0.077B 0.00
Clearside Biomedical (CLSD) United States $0.074B 0.00
Selecta Biosciences (SELB) United States $0.074B 0.00
Trevena (TRVN) United States $0.069B 0.00
Liquidia Technologies (LQDA) United States $0.068B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.066B 0.00
Prima BioMed (IMMP) Australia $0.066B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.066B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.066B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.065B 0.00
Organovo Holdings (ONVO) United States $0.065B 0.00
NewLink Genetics (NLNK) United States $0.061B 0.00
Catalyst Biosciences (CBIO) United States $0.059B 0.00
Pluristem Therapeutics (PSTI) Israel $0.054B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.051B 0.00
AIT Therapeutics (XAIR) United States $0.051B 0.00
Curis (CRIS) United States $0.050B 0.00
Applied Genetic Technologies (AGTC) United States $0.050B 0.00
Checkpoint Therapeutics (CKPT) United States $0.049B 0.00
Idera Pharmaceuticals (IDRA) United States $0.046B 0.00
Orgenesis (ORGS) United States $0.046B 2.97
DiaMedica Therapeutics (DMAC) United States $0.045B 0.00
AquaBounty Technologies (AQB) United States $0.044B 0.00
Vascular Biogenics (VBLT) Israel $0.044B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.041B 0.00
Alimera Sciences (ALIM) United States $0.041B 0.00
Celsion (CLSN) United States $0.037B 0.00
Evogene (EVGN) Israel $0.036B 0.00
Oncobiologics (OTLK) United States $0.035B 0.00
Celldex Therapeutics (CLDX) United States $0.035B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.035B 0.00
Stellar Biotechnologies (EDSA) Canada $0.032B 0.00
VistaGen Therapeutics (VTGN) United States $0.030B 0.00
Apricus Biosciences (SEEL) United States $0.030B 0.00
VIVUS (VVUS) United States $0.030B 0.00
Fibrocell Science Inc (FCSC) United States $0.029B 16.67
BioCardia (BCDA) United States $0.028B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.027B 0.00
Bionano Genomics (BNGO) United States $0.027B 0.00
Novogen (KZIA) Australia $0.027B 0.00
Aptevo Therapeutics (APVO) United States $0.027B 0.00
Soligenix (SNGX) United States $0.026B 0.00
Caladrius Biosciences (CLBS) United States $0.026B 0.00
Entera Bio (ENTX) Israel $0.026B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.023B 0.00
CollPlant Holdings (CLGN) Israel $0.021B 0.00
Signal Genetics (MGEN) United States $0.020B 0.00
Aytu Bioscience (AYTU) United States $0.019B 0.00
Pulmatrix (PULM) United States $0.017B 0.00
Unum Therapeutics (UMRX) United States $0.016B 0.00
AEterna Zentaris (AEZS) United States $0.016B 0.00
IMMURON (IMRN) Australia $0.014B 0.00
TOCAGEN INC (TOCA) United States $0.013B 0.00
MYOS RENS Technology (MYOS) United States $0.013B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
Advaxis (ADXS) United States $0.011B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.011B 0.00
TrovaGene (TROV) United States $0.010B 0.00
Titan Pharmaceuticals (TTNP) United States $0.009B 0.00
Genetic Technologies (GENE) Australia $0.009B 0.00
TRACON Pharmaceuticals (TCON) United States $0.008B 0.00
Cesca Therapeutics (THMO) United States $0.008B 0.00
Cleveland BioLabs (CBLI) United States $0.008B 0.00
Benitec Biopharma (BNTC) Australia $0.006B 0.00
Neuralstem (SNCA) United States $0.003B 0.00